ctrl K

Price Alert

Bright Minds Biosciences ... (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

41.80

-0.74 (-1.74%)

At close: Aug 15, 2025, 3:59 PM

42.00

0.47%

After-hours: Aug 15, 2025, 06:45 PM EDT

Bright Minds Biosciences Balance Sheet Statement

Financials in CAD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	5.72M	6.75M	11.63M	19.76M
Short-Term Investments	n/a	86.25K	86.25K	86.25K
Long-Term Investments	n/a	n/a	n/a	33.68K
Other Long-Term Assets	n/a	n/a	-0.00	-33.68K
Receivables	50.22K	n/a	155.78K	110.15K
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	5.99M	6.81M	11.95M	20.04M
Property-Plant & Equipment	117.66K	66.41K	138.86K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	2K
Total Long-Term Assets	117.66K	66.41K	138.86K	2K
Total Assets	6.1M	6.88M	12.09M	20.04M
Account Payables	407.55K	182.31K	1.25M	596.57K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a
Total Current Liabilities	528.68K	280.86K	1.47M	638.57K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	39.58K	n/a	71.98K	n/a
Total Liabilities	568.26K	280.86K	1.54M	638.57K
Total Debt	118.96K	73.55K	139.91K	n/a
Common Stock	35.42M	33.91M	32.24M	27.08M
Retained Earnings	-34.35M	-31.55M	-24.17M	-9.21M
Comprehensive Income	4.01M	3.4M	2.48M	1.57M
Shareholders Equity	5.54M	6.6M	10.54M	19.4M
Total Investments	n/a	86.25K	86.25K	119.93K